MAPT and Alzheimer disease: For example, relevant studies in AD have demonstrated that tau pathology correlates with the severity of dementia and neuronal loss in human cases (Riley, Snowdon, & Markesbery, 2002), and multiples findings in AD animal models have shown that synaptic and cognitive deficits depend on tau (Ittner et al., 2010).